142 related articles for article (PubMed ID: 9305741)
1. Purification and characterization of PAMP-12 (PAMP[9-20]) in porcine adrenal medulla as a major endogenous biologically active peptide.
Kuwasako K; Kitamura K; Ishiyama Y; Washimine H; Kato J; Kangawa K; Eto T
FEBS Lett; 1997 Sep; 414(1):105-10. PubMed ID: 9305741
[TBL] [Abstract][Full Text] [Related]
2. Identification and hypotensive activity of proadrenomedullin N-terminal 20 peptide (PAMP).
Kitamura K; Kangawa K; Ishiyama Y; Washimine H; Ichiki Y; Kawamoto M; Minamino N; Matsuo H; Eto T
FEBS Lett; 1994 Aug; 351(1):35-7. PubMed ID: 8076689
[TBL] [Abstract][Full Text] [Related]
3. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
[TBL] [Abstract][Full Text] [Related]
4. Distribution and molecular forms of adrenomedullin and proadrenomedullin N-terminal 20 peptide in the porcine gastrointestinal tract.
Kiyomizu A; Kitamura K; Kawamoto M; Eto T
J Gastroenterol; 2001 Jan; 36(1):18-23. PubMed ID: 11211206
[TBL] [Abstract][Full Text] [Related]
5. Adrenomedullin (11-26): a novel endogenous hypertensive peptide isolated from bovine adrenal medulla.
Kitamura K; Matsui E; Kato J; Katoh F; Kita T; Tsuji T; Kangawa K; Eto T
Peptides; 2001 Nov; 22(11):1713-8. PubMed ID: 11754956
[TBL] [Abstract][Full Text] [Related]
6. Distribution and characterization of rat immunoreactive proadrenomedullin N-terminal 20 peptide (PAMP) and the augmented cardiac PAMP in spontaneously hypertensive rat.
Inatsu H; Sakata J; Shimokubo T; Kitani M; Nishizono M; Washimine H; Kitamura K; Kangawa K; Matsuo H; Eto T
Biochem Mol Biol Int; 1996 Feb; 38(2):365-72. PubMed ID: 8850532
[TBL] [Abstract][Full Text] [Related]
7. Immunoreactive proadrenomedullin N-terminal 20 peptide in human tissue, plasma and urine.
Washimine H; Kitamura K; Ichiki Y; Yamamoto Y; Kangawa K; Matsuo H; Eto T
Biochem Biophys Res Commun; 1994 Jul; 202(2):1081-7. PubMed ID: 8048921
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma proadrenomedullin N-terminal 20 peptide in patients with essential hypertension.
Kuwasako K; Kitamura K; Kangawa K; Ishiyama Y; Kato J; Eto T
Ann Clin Biochem; 1999 Sep; 36 ( Pt 5)():622-8. PubMed ID: 10505213
[TBL] [Abstract][Full Text] [Related]
9. [Adrenomedullin and PAMP].
Kitamura K; Eto T
Nihon Rinsho; 1997 Aug; 55(8):1963-70. PubMed ID: 9284408
[TBL] [Abstract][Full Text] [Related]
10. Adrenomedullin and proadrenomudullin N-terminal 20 peptide (PAMP) are present in human colonic epithelia and exert an antimicrobial effect.
Marutsuka K; Nawa Y; Asada Y; Hara S; Kitamura K; Eto T; Sumiyoshi A
Exp Physiol; 2001 Sep; 86(5):543-5. PubMed ID: 11571480
[TBL] [Abstract][Full Text] [Related]
11. Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels.
Etoh T; Kato J; Takenaga M; Imamura T; Kitamura K; Koiwaya Y; Eto T
Clin Cardiol; 1999 Feb; 22(2):113-7. PubMed ID: 10068849
[TBL] [Abstract][Full Text] [Related]
12. Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) in adrenal chromaffin cells.
Kobayashi H; Yanagita T; Yokoo H; Wada A
Peptides; 2001 Nov; 22(11):1895-901. PubMed ID: 11754978
[TBL] [Abstract][Full Text] [Related]
13. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
[TBL] [Abstract][Full Text] [Related]
14. A newly identified peptide, proadrenomedullin N-terminal 20 peptide, induces hypotensive action via pertussis toxin-sensitive mechanisms.
Shimosawa T; Ando K; Fujita T
Hypertension; 1997 Nov; 30(5):1009-14. PubMed ID: 9369247
[TBL] [Abstract][Full Text] [Related]
15. Proadrenomedullin N-terminal 20 peptide inhibits aldosterone secretion of human adrenocortical and Conn's adenoma cells: comparison with adrenomedullin effect.
Andreis PG; Tortorella C; Mazzocchi G; Nussdorfer GG
J Clin Endocrinol Metab; 1998 Jan; 83(1):253-7. PubMed ID: 9435451
[TBL] [Abstract][Full Text] [Related]
16. Decrease of TSH levels and epithelium/colloid ratio in rat thyroid glands following administration of proadrenomedullin N-terminal peptide (12-20).
Ginda WJ; Nowak KW; Malendowicz LK
Horm Metab Res; 2000 Jan; 32(1):10-4. PubMed ID: 10727007
[TBL] [Abstract][Full Text] [Related]
17. Proadrenomedullin N-terminal 20 peptide: minimal active region to regulate nicotinic receptors.
Mahata M; Mahata SK; Parmer RJ; O'Connor DT
Hypertension; 1998 Nov; 32(5):907-16. PubMed ID: 9822452
[TBL] [Abstract][Full Text] [Related]
18. Secretion of proadrenomedullin N-terminal 20 peptide from cultured neonatal rat cardiac cells.
Tsuruda T; Kato J; Kitamura K; Kuwasako K; Imamura T; Koiwaya Y; Kangawa K; Eto T
Life Sci; 2001 Jun; 69(2):239-45. PubMed ID: 11441914
[TBL] [Abstract][Full Text] [Related]
19. Hypotensive effect of a newly identified peptide, proadrenomedullin N-terminal 20 peptide.
Shimosawa T; Fujita T
Hypertension; 1996 Sep; 28(3):325-9. PubMed ID: 8794811
[TBL] [Abstract][Full Text] [Related]
20. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions.
Kitamura K; Kangawa K; Eto T
Microsc Res Tech; 2002 Apr; 57(1):3-13. PubMed ID: 11921351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
